<DOC>
	<DOCNO>NCT02296138</DOCNO>
	<brief_summary>The overall objective ass effect daily tiotropium + olodaterol fix dose combination compare 5 µg tiotropium ( deliver Respimat® inhaler ) moderate severe COPD exacerbation patient severe severe COPD .</brief_summary>
	<brief_title>Comparing Efficacy Tiotropium + Olodaterol ( 5/5 µg ) Fixed Dose Combination ( FDC ) Over Tiotropium 5µg Reducing Moderate Severe Exacerbations Patients With Severe Very Severe Chronic Obstructive Pulmonary Disease .</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Olodaterol</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Inclusion criterion : Male female patient , 40 year age old . Diagnosis COPD document postbronchodilator Forced expiratory volume one second ( FEV1 ) &lt; 60 % predict normal postbronchodilator FEV1/FVC ( Forced vital capacity ) &lt; 70 % Visit 1 Documented history least one moderate severe COPD exacerbation previous 12 month require treatment systemic corticosteroid and/or antibiotic and/or related hospitalization . Symptomatically stable define : evidence COPD exacerbation require use either antibiotic and/or steroid 4 week prior visit 1 evidence change usual COPD medication 4 week prior visit 1 . Current exsmokers smoke history 10 pack year . Exclusion criterion : Significant disease COPD . Clinically relevant abnormal baseline haematology , blood chemistry creatinine &gt; x2 ULN exclude regardless clinical condition . ( A repeat laboratory evaluation conduct deemed necessary investigator . ) Current document diagnosis asthma . For patient allergic rhinitis atopy , source documentation require verify patient asthma A diagnosis thyrotoxicosis A history myocardial infarction within 6 month screen visit . Lifethreatening cardiac arrhythmia . Known active tuberculosis . Any malignancy unless free disease least 5 year ( patient treat basal cell carcinoma squamous cell skin cancer allow ) . A history cystic fibrosis . Clinically relevant bronchiectasis . Patients severe emphysema require endobronchial intervention within 6 month prior screen A history significant alcohol drug abuse opinion investigator . Patients undergone thoracotomy pulmonary resection Patients treat oral patch ßadrenergics . Patients treat oral corticosteroid medication unstable dose Patients treated antibiotic reason within 4 week screen visit Patients treat PDE4 inhibitor within 3 month screen visit Patients take investigational drug within one month six halflives Pregnant nursing woman . Women childbearing potential use highly effective method birth control .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>